These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11298463)

  • 1. Putrescine, DNA, RNA and protein contents in human uterine, breast and rectal cancer.
    Bandopadhyay M; Ganguly AK
    J Postgrad Med; 2000; 46(3):172-5. PubMed ID: 11298463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary breast-ovarian cancer: how can we use the new DNA markers to improve patient management?
    Narod S
    Clin Invest Med; 1993 Aug; 16(4):314-7. PubMed ID: 8306541
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The concentration of tissue--type plasminogen activator (t-PA) in extracts of breast cancer tissue].
    Ziółkowska E; Pietrusińska E; Łozyńska-Podhrebelna D
    Pol Merkur Lekarski; 2008 Dec; 25(150):489-94. PubMed ID: 19205379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal residual disease detection in breast cancer: improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR.
    Fellowes VS; Husebekk A; Gress RE; Vance BA
    Int J Oncol; 2004 Apr; 24(4):861-7. PubMed ID: 15010823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The accessory diagnosis of rectal carcinoma by ICM and oncogene expressions].
    Wang J; Zhang Y; Quan Z
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):338-40. PubMed ID: 11829854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
    J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
    Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
    Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
    Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
    Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale proteomics analysis of human ovarian cancer for biomarkers.
    Bengtsson S; Krogh M; Szigyarto CA; Uhlen M; Schedvins K; Silfverswärd C; Linder S; Auer G; Alaiya A; James P
    J Proteome Res; 2007 Apr; 6(4):1440-50. PubMed ID: 17315909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does variability in carotenoid composition and concentration in tissues of the breast and reproductive tract in women depend on type of lesion?
    Czeczuga-Semeniuk E; Wołczyński S
    Adv Med Sci; 2008; 53(2):270-7. PubMed ID: 19095580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ThinPrep-processed fine-needle samples of breast are effective material for RNA- and DNA-based molecular diagnosis: application to p53 mutation analysis.
    Tisserand P; Fouquet C; Marck V; Mallard C; Fabre M; Vielh P; Soussi T
    Cancer; 2003 Aug; 99(4):223-32. PubMed ID: 12925984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study.
    Fong PY; Xue WC; Ngan HY; Chan KY; Khoo US; Tsao SW; Chiu PM; Man LS; Cheung AN
    Cancer; 2005 Jan; 103(2):268-76. PubMed ID: 15578716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery.
    Kuerer HM; Goldknopf IL; Fritsche H; Krishnamurthy S; Sheta EA; Hunt KK
    Cancer; 2002 Dec; 95(11):2276-82. PubMed ID: 12436432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
    Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
    Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.